Skip to main content
Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

Publisher: Bentham Science Publishers

More about this publication?
Volume 4, Number 3, 2008

Articles

Favourites:
ADD

Fatty Acid Synthase: A Target for the Reversal of Liver Steatosis
pp. 100-108(9)
Authors: Evans, Zachary P.; Ellett, Justin D.; Chavin, Kenneth D.

Favourites:
ADD

The NPC1L1 Inhibitor Ezetimibe in the Treatment of the Dyslipidemia in Patients Affected by the Metabolic Syndrome: Evidences and Perspectives
pp. 109-120(12)
Authors: Anfossi, Giovanni; Frascaroli, Chiara; Bonomo, Katia; Chirio, Massimo; Giordanino, Chiara; Trovati, Mariella

Favourites:
ADD

Recent Findings on the Multifaceted Functionality of Enzyme Inhibition by Natural Compounds: A Review
pp. 121-152(32)
Authors: Delano-Frier, John P.; Castro-Guillen, Jose Luis; Blanco-Labra, Alejandro

Favourites:
ADD

Aurora B Kinase and Passenger Proteins as Targets for Cancer Therapy
pp. 153-159(7)
Authors: Nhung Hoang, Thi M.; Delacour-Larose, Marlene; Molla, Annie

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content